20 min listen
Dr. Ingmar Gorman, Fluence
ratings:
Length:
33 minutes
Released:
May 25, 2021
Format:
Podcast episode
Description
In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").In our conversation with Dr. Gorman, we learn about the educational and training resources Fluence is focused on developing to address the growing interest in psychedelic integration and psychedelic-assisted psychotherapy. Dr. Gorman is also kind enough to share his expertise and perspective as it relates to the encouraging results recently released surrounding the Phase 3 Trials testing MDMA-assisted psychotherapy for PTSD conducted by MAPS, and what it potentially means for the future of MDMA-assisted psychotherapy.*To learn more about the company featured in this episode and the work they’re doing, visit their website: FluenceTraining.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 19, 2021.
Released:
May 25, 2021
Format:
Podcast episode
Titles in the series (100)
Nico Grundmann & Tiffany Franke, Ember Health: Global Trac Solutions, Inc. CEO, David Flores, chats with Ember Health Founder & Chief Medical Officer, Nico Grundmann, MD/MBA, along with Founder & Chief Experience Officer, Tiffany Franke. In this episode, the duo emphasizes how Ember Health is working to provide safe, effective ketamine therapy for people seeking relief from depression and so much more. by Psychedelic Spotlight Podcast